PP
SNDX icon

PDT Partners’s Syndax Pharmaceuticals SNDX Stock Holding History

PDT Partners’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-12,200
Closed -$134K – 809
2020
Q1 		$134K Buy
+12,200
New +$114K 0.01% 597
2018
Q2 		– Sell
-110,866
Closed -$1.58M – 570
2018
Q1 		$1.58M Buy
110,866
+54,211
+96% +$575K 0.05% 310
2017
Q4 		$496K Buy
+56,655
New +$561K 0.01% 426

Other funds holding SNDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

PDT Partners's SNDX Position: Q2 2020 in Review

PDT Partners sold out of Syndax Pharmaceuticals (SNDX) in Q2 2020, closing a stake of 12,200 shares — an estimated $134K sold.

PDT Partners first reported a position in SNDX in Q4 2017 and held it in 3 quarters. The position peaked at $1.58M in Q1 2018. 97 funds tracked by Wall St. Rank hold SNDX as of Q2 2020.

  • PDT Partners reported no remaining Syndax Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • PDT Partners sold 12,200 Syndax Pharmaceuticals shares in Q2 2020, an estimated $134K.
  • PDT Partners first reported a position in Syndax Pharmaceuticals in Q4 2017 and held it in 3 quarters.
  • PDT Partners's Syndax Pharmaceuticals position peaked at $1.58M in Q1 2018.
  • 97 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2020.

Based on PDT Partners's 13F filing for Q2 2020, filed 14 Aug 2020.